Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3

October 4, 2021 updated by: Daniel Cox, PhD, University of Virginia
It is a common clinical practice to leave small amounts of astigmatism uncorrected in contact lens wearers. Therefore, some drivers who have astigmatism and wear contact lenses may experience blur while driving. The purpose of this study is to determine if correcting small amounts of astigmatism with contact lenses will improve driving safety.

Study Overview

Detailed Description

The purpose of this randomized control trial is to compare visual performance and simulated driving performance of adults with astigmatism when wearing 1*DAY ACUVUE® MOIST for ASTIGMATISM (toric), 1*DAY ACUVUE® MOIST (spherical control), and 1*DAY ACUVUE® MOIST (placebo) contact lenses. Adult subjects with nearsightedness and astigmatism will wear three types of soft contact lenses (placebo, spherical and toric in randomized order). Each subject will read letters on standard eye charts and complete vision and driving tests in a driving simulator. Subjects will repeat these tests with each lens type. Analyses will include an ANOVA to look for a main effect of lens condition, and separate contrasts to compare toric vs. spherical, toric vs. placebo, and spherical vs. placebo lenses. Investigating the lenses under simulated driving conditions, which involve eye movement demands, will lend insight into the potential advantages of toric over spherical contact lenses for driving safety.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Charlottesville, Virginia, United States, 22908
        • University of Virginia Driving Safety Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult licensed driver
  • Ages 18-39 years
  • Corrected vision of 20/40 or better in each eye
  • Astigmatism between 0.75 and 1.75 diopters in each eye
  • Nearsightedness between 0 and -9 diopters in each eye
  • No active eye infection
  • No defective peripheral vision
  • No bifocal correction
  • Routinely wears toric contact lenses (more than 4 times per week)
  • Routinely drives a car (more than 4 times per week)
  • No history of motion, sea, or big screen (e.g. IMAX) sickness, and no persistent Simulation Adaptation Syndrome

Exclusion Criteria:

  • Corrected vision worse than 20/40 in either eye
  • No astigmatism in either eye
  • Active eye infection
  • Defective peripheral vision
  • Wears bifocals
  • Wears contact lenses less than 4 times per week
  • Drives infrequently (less than 4 times per week)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Placebo, Spherical, then Toric Lenses
Crossover order 1
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
Experimental: Placebo, Toric, then Spherical Lenses
Crossover order 2
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
Experimental: Spherical, Placebo, then Toric Lenses
Crossover order 3
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
Experimental: Spherical, Toric, then Placebo Lenses
Crossover order 4
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
Experimental: Toric, Placebo, then Spherical Lenses
Crossover order 5
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses
Experimental: Toric, Spherical, then Placebo Lenses
Crossover order 6
AcuVue Oasys Bandage Lenses with no prescription
1-DAY ACUVUE® MOIST contact lenses
1-DAY ACUVUE® MOIST for ASTIGMATISM contact lenses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tactical Composite Score
Time Frame: 1 day
This scale measures driving performance in the simulator. It is the sum of the z scores from 15 different driving simulator variables related to braking, steering, speed control and judgment. The scale has no fixed limits. A score of 0 indicates average performance. Higher scores indicate better performance.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operational Composite Score
Time Frame: 1 day
This scale measures driving-relevant visual performance. It is the sum of the z scores from 5 different driving simulator variables related to visual testing done in the simulator. The scale has no fixed limits. A score of 0 indicates average performance. Higher scores indicate better performance.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel J Cox, PhD, University of Virginia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2016

Primary Completion (Actual)

February 1, 2017

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

October 28, 2016

First Submitted That Met QC Criteria

October 28, 2016

First Posted (Estimate)

November 1, 2016

Study Record Updates

Last Update Posted (Actual)

October 6, 2021

Last Update Submitted That Met QC Criteria

October 4, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18499

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Data and protocol will be shared on request.

IPD Sharing Time Frame

Data will be available on request

IPD Sharing Access Criteria

data will be shared via e-mail.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on Placebo Lenses

3
Subscribe